EcoDrugPlus

Glutamate Receptor, Metabotropic 3

Ensembl ID : ENSIPUG00000006501
Gene Symbol: GRM3
4 Cross references
215 Possible Orthologues:

Glutamate Receptor, Metabotropic 5a

Ensembl ID : ENSIPUG00000011921
Gene Symbol: GRM5A
3 Cross references
211 Possible Orthologues:

Glutamate Receptor, Metabotropic 5b

Ensembl ID : ENSIPUG00000002532
Gene Symbol: GRM5B
2 Cross references
218 Possible Orthologues:

Glutaminase

Ensembl ID : ENSIPUG00000009369
Gene Symbol: GLS
3 Cross references
233 Possible Orthologues:

Glutathione S-Transferase P

Ensembl ID : ENSIPUG00000012349
Gene Symbol: LOC108275325
3 Cross references
161 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha B

Ensembl ID : ENSIPUG00000005965
Gene Symbol: GSK3AB
3 Cross references
186 Possible Orthologues:

Glycogen Synthase Kinase 3 Beta, Genome Duplicate A

Ensembl ID : ENSIPUG00000023868
Gene Symbol: GSK3BA
3 Cross references
230 Possible Orthologues:

Glycogen Synthase Kinase 3 Beta, Genome Duplicate B

Ensembl ID : ENSIPUG00000015272
Gene Symbol: GSK3BB
4 Cross references
229 Possible Orthologues:

Gonadotropin Releasing Hormone Receptor

Ensembl ID : ENSIPUG00000003591
Gene Symbol: GNRHR
1 Cross references
155 Possible Orthologues:

Gonadotropin-Releasing Hormone Ii Receptor

Ensembl ID : ENSIPUG00000021476
Gene Symbol: LOC108256797
4 Cross references
135 Possible Orthologues:

Granzyme B(G,h)

Ensembl ID : ENSIPUG00000012627
Gene Symbol: LOC108267046
3 Cross references
996 Possible Orthologues:

Growth Hormone Secretagogue Receptor A

Ensembl ID : ENSIPUG00000008055
Gene Symbol: GHSRA
1 Cross references
199 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).